FIELD: medicine.
SUBSTANCE: the method deals with 2 courses of polychemotherapy at the first stage due to regional intra-arterial introduction of cisplatin at the dosage of 100 mg/m2 during the first day of every course and 6-h-long intra-arterial infusion of 5-fluorouracil at total dose of 750 mg/m2 in the morning since the 2nd to the 6th d of every course. Chemotherapy should be performed at the background of total magnetotherapy at frequency of magnetic field being 98-112 Hz, intensity of 25-30 oersted, duration of every seance being 30 min, the number of seances corresponds to the duration of chemotherapeutic courses. At the second stage in 2-3 wk after finishing chemotherapy it is necessary to conduct the course of distance radiation therapy (DRT) at multifractioning the dosage by SFD being 1.2 Gy twice daily 5 times weekly up to TFD being equivalent to TDF (time-dosage-fraction) of 62-70 Gy onto primary focus and 40-46 Gy onto areas of regional lymph outflow. As modifiers one should apply cisplatin during the first 2 wk of radiation therapy, hyperbaric oxygenation during the first 10 d of radiation therapy and total magnetotherapy since the 11th d of DRT course till its ending. At the third stage in case of residual metastases in lymph nodes of patient's neck in 2-3 wk after the end of radiation therapy one should conduct operative interference in lymph outflow pathways. The method enables to decrease toxicity of chemo-and radiation therapy due to decreased radiation reactions, stimulation of immune system and improved microcirculation.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH RECURRENT THORACIC ESOPHAGUS CANCER IN ESOPHAGEAL-GASTRIC ANASTOMOSIS | 2019 |
|
RU2728192C1 |
METHOD FOR TREATING PATIENTS FOR LOCALLY SPREAD CARCINOMA CASES LOCALIZED IN MUCOUS MEMBRANE OF ORAL CAVITY AND ORAL DIVISION OF THE PHARYNX | 2003 |
|
RU2240117C1 |
METHOD FOR TREATMENT OF PATIENTS WITH LOCALLY SPREAD SQUAMOUS CELL LARYNX CANCER | 2005 |
|
RU2303446C2 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2009 |
|
RU2401139C1 |
METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
METHOD FOR COMBINED TREATMENT OF PATIENTS WITH LARYNGEAL AND LARYNGOPHARYNGEAL CANCER | 2016 |
|
RU2634784C1 |
METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 |
|
RU2429032C1 |
METHOD OF PREDICTING EFFICIENCY OF TREATING PATIENTS WITH NASOPHARYNGEAL CANCER | 2011 |
|
RU2475748C2 |
Authors
Dates
2005-07-10—Published
2003-11-03—Filed